New cancer drug enters first human trials
Disease control
Recruiting now
This is the first study in humans testing a new drug called IPH4502 for patients with advanced solid tumors that have spread or cannot be removed by surgery. The main goals are to find a safe dose, check for side effects, and look for early signs that the drug might help control …
Phase: PHASE1 • Sponsor: Innate Pharma • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC